Sort
3,198 grants matching “mrna vaccine”
STRUCTURE AND FUNCTION OF THE CORONAVIRUS REPLICASE
$402,937Loyola University Chicago · R01 · FY2004 · AI
Mechanism of CsrA-Mediated Global Control
$402,900Tony Romeo · University Of Florida · R01 · FY2014 · GM
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · DK
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · DK
The Untranslated 3'End of SARS-CoV-2 RNA as a Determinant of Obesity-Accelerated Infectivity
$402,500Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · DK
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$402,460Robert M Prins · University Of California Los Angeles · R01 · FY2023 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$402,457Robert M Prins · University Of California Los Angeles · R01 · FY2022 · CA
Respiratory Syncytial Virus Polymerase Protein and Promoter Interactions
$402,188Rachel Fearns · Boston University Medical Campus · R01 · FY2010 · AI
Using Chemical Biology to Interfere with the Influenza Virus Life Cycle
$401,105Michael G Roth · Ut Southwestern Medical Center · R01 · FY2012 · AI
NOVEL VACCINE TARGETS FOR EARLY STAGE BREAST CANCER
$401,066Benaroya Research Inst At Virginia Mason · R01 · FY2002 · CA
Biomaterials that Promote Infection Immunity
$400,471James D. Bryers · University Of Washington · R56 · FY2015 · AI
Using Chemical Biology to Interfere with the Influenza Virus Life Cycle
$400,455Michael G Roth · Ut Southwestern Medical Center · R01 · FY2011 · AI
Future Directions: Latency and Immune Receptors
$400,365Christopher P. Hill · University Of Utah · P50 · FY2021 · AI
The roles of biologically relevant ncRNAs
$400,266Sarah M Fortune · Harvard School Of Public Health · U19 · FY2017 · AI
Leukocyte Signaling in the Elderly and Vaccine Immunogenicity
$400,000David Bram Lewis · Stanford University · R01 · FY2010 · AI
Control of Translation in Herpesvirus Infected Cells
$399,509Ian J. Mohr · New York University School Of Medicine · R01 · FY2019 · GM
Control of Translation in Herpesvirus Infected Cells
$399,509Ian J. Mohr · New York University School Of Medicine · R01 · FY2018 · GM
Highly stable mini-circRNA vaccine with maximally activated and long-lasting T cells for HPV-related cancer combination immunotherapy
$398,823Gordon Parry · Ampedrna Biosciences Llc · R43 · FY2024 · CA
Control of protective immunity by innate pathways sensing bacterial viability
$398,325Julie Magarian Blander · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · AI
Respiratory Syncytial Virus Polymerase Protein and Promoter Interactions
$398,166Rachel Fearns · Boston University Medical Campus · R01 · FY2011 · AI
Protein Phosphorylation in Trypanosomes
$397,916Marilyn Parsons · Seattle Biomedical Research Institute · R01 · FY2006 · AI
Rational and Combinatorial Design of Immunogens to Elicit 2G12-like Antibodies
$397,874Isaac Jonathan Krauss · Brandeis University · R01 · FY2013 · AI
Endosomal escape of lipid-based nanoparticles comprising Gaussian curvature lipids
$397,651Cecilia Maria Leal · University Of Illinois At Urbana-Champaign · R01 · FY2022 · GM
RNA DELIVERY FOR DENDRITIC CELL HIV ANTIGEN PREVENTION
$396,250University Of Pennsylvania · R01 · FY2004 · AI
RNA DELIVERY FOR DENDRITIC CELL HIV ANTIGEN PREVENTION
$396,250University Of Pennsylvania · R01 · FY2003 · AI